FDA Drugs recall ·
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz)… recall
- Recall number
- D-0291-2026
- Date
- (initiated December 22, 2025)
- Company / brand
- Cipla USA, Inc.
10 Independence Blvd, Warren, NJ, United States - Category
- Drugs › Class III
- Classification
- Class III
- Status
- Ongoing
- Units affected
- 92,376 tubes
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
Why was it recalled?
Failed PH Specifications
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Batch XHBG; Exp. 08/31/2027
Distribution
Nationwide in the USA
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (drugs), recall D-0291-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.